LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN was reported 13841 times

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POSITRON EMISSION TOMOGRAM PROSTATE 2 0.6667
1 COAGULATION FACTOR MUTATION 1 0.2000
2 HORMONE-DEPENDENT PROSTATE CANCER 10 0.1429
3 HORMONE-REFRACTORY PROSTATE CANCER 167 0.1406
4 GASTRIN-RELEASING PEPTIDE PRECURSOR INCREASED 1 0.1000
5 ANTERIOR SEGMENT NEOVASCULARISATION 1 0.0833
6 NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC 1 0.0769
7 CARCINOID TUMOUR OF THE PROSTATE 1 0.0667
8 ILL-DEFINED DISORDER 3641 0.0599
9 GENERAL PHYSICAL HEALTH DETERIORATION 6684 0.0577
10 MENINGEAL THICKENING 1 0.0526
11 FREE PROSTATE-SPECIFIC ANTIGEN DECREASED 1 0.0526
12 METASTASES TO NERVOUS SYSTEM 9 0.0489
13 BIOPSY PROSTATE ABNORMAL 1 0.0476
14 PROSTATIC SPECIFIC ANTIGEN DECREASED 15 0.0397
15 INCOMPLETE SPINAL FUSION 1 0.0357
16 ACTINOMYCES BACTERAEMIA 1 0.0345
17 ACTIVATED PROTEIN C RESISTANCE 1 0.0303
18 FIBRIN D DIMER 1 0.0270
19 CANCER WITH A HIGH TUMOUR MUTATIONAL BURDEN 1 0.0256
20 PROSTATE CANCER METASTATIC 84 0.0251
21 EXPOSURE TO RADIATION 3 0.0238
22 CANCER CELLS PRESENT 1 0.0233
23 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 24 0.0231
24 METASTASES TO PITUITARY GLAND 1 0.0222
25 HYPERTENSIVE ANGIOPATHY 1 0.0222
26 LIGAMENTUM FLAVUM HYPERTROPHY 1 0.0217
27 PROSTATIC SPECIFIC ANTIGEN INCREASED 287 0.0208
28 BLOOD CHROMOGRANIN A INCREASED 9 0.0196
29 SOFT TISSUE MASS 9 0.0195
30 MANUFACTURING PRODUCTION ISSUE 2 0.0192
31 SALIVARY HYPOSECRETION 3 0.0185
32 FULL BLOOD COUNT 1 0.0175
33 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 4 0.0174
34 MEAN CELL HAEMOGLOBIN CONCENTRATION 1 0.0164
35 OCULAR MELANOMA 1 0.0161
36 METASTASES TO BONE MARROW 8 0.0160
37 NEURECTOMY 1 0.0154
38 MALIGNANT GENITOURINARY TRACT NEOPLASM 1 0.0149
39 METASTASES TO SPLEEN 6 0.0145
40 MALIGNANT PALATE NEOPLASM 1 0.0143
41 ACQUIRED HAEMOPHILIA 14 0.0140
42 SALIVARY GLAND PAIN 3 0.0139
43 METASTASES TO PROSTATE 1 0.0137
44 KIDNEY CONGESTION 2 0.0129
45 TYPE IIA HYPERLIPIDAEMIA 3 0.0128
46 HAEMATOLOGY TEST ABNORMAL 4 0.0125
47 DIASTASIS RECTI ABDOMINIS 2 0.0124
48 ACUTE MYELOMONOCYTIC LEUKAEMIA 3 0.0119
49 PROSTATE CANCER RECURRENT 7 0.0114
50 METASTASES TO PELVIS 7 0.0111
51 VASCULAR COMPRESSION 3 0.0095
52 SARS-COV-2 TEST POSITIVE 121 0.0092
53 LABORATORY TEST ABNORMAL 266 0.0090
54 TRAUMATIC LIVER INJURY 2 0.0085
55 INTRAOCULAR PRESSURE TEST 2 0.0083
56 BONE MARROW INFILTRATION 3 0.0078
57 BODY SURFACE AREA INCREASED 1 0.0078
58 SPINAL CORD INFECTION 5 0.0077
59 BONE CANCER METASTATIC 4 0.0076
60 LABORATORY TEST 1 0.0074
61 ANAEMIA OF MALIGNANT DISEASE 2 0.0071
62 IMMATURE GRANULOCYTE COUNT INCREASED 2 0.0071
63 MALIGNANT TRANSFORMATION 3 0.0067
64 METASTASES TO BONE 103 0.0063
65 METASTASES TO SPINE 21 0.0062
66 MEDIASTINUM NEOPLASM 1 0.0060
67 TUMOUR FLARE 4 0.0059
68 NEUROENDOCRINE CARCINOMA 4 0.0058
69 RADICULAR PAIN 2 0.0057
70 HYDROURETER 2 0.0053
71 MELANODERMA 1 0.0052
72 CYSTITIS RADIATION 1 0.0052
73 METASTASES TO SPINAL CORD 1 0.0052
74 GRANULOCYTOSIS 1 0.0051
75 GRANULOCYTES ABNORMAL 1 0.0050
76 ACUTE CHOLECYSTITIS NECROTIC 1 0.0050
77 SACRAL PAIN 3 0.0049
78 LENS DISLOCATION 1 0.0048
79 IRON BINDING CAPACITY TOTAL DECREASED 1 0.0045
80 BLADDER HYPERTROPHY 2 0.0045
81 CARCINOID CRISIS 1 0.0044
82 CREATININE RENAL CLEARANCE ABNORMAL 2 0.0043
83 CANCER PAIN 11 0.0043
84 PEPTIC ULCER 14 0.0042
85 BLOOD CREATINE ABNORMAL 2 0.0041
86 INGUINAL MASS 1 0.0039
87 HYPHAEMA 2 0.0038
88 HERPES ZOSTER REACTIVATION 1 0.0038
89 BASOPHIL COUNT DECREASED 1 0.0038
90 GASTROINTESTINAL PROCEDURAL COMPLICATION 1 0.0037
91 ABSCESS INTESTINAL 8 0.0037
92 BLOOD CHOLINESTERASE DECREASED 1 0.0036
93 METASTASES TO NECK 1 0.0036
94 HAEMORRHAGIC ASCITES 1 0.0035
95 HAEMATOTOXICITY 33 0.0035
96 ABDOMINAL LYMPHADENOPATHY 3 0.0035
97 XEROPHTHALMIA 2 0.0034
98 MALIGNANT NEOPLASM PROGRESSION 343 0.0033
99 BLOOD CREATINE DECREASED 1 0.0033
100 BLADDER TAMPONADE 1 0.0033
101 METASTASES TO LYMPH NODES 22 0.0033
102 NEOPLASM PROSTATE 1 0.0032
103 SPINAL CORD COMPRESSION 12 0.0031
104 BLOOD OSMOLARITY INCREASED 1 0.0030
105 DISEASE PROGRESSION 360 0.0030
106 SPINAL CORD DISORDER 5 0.0030
107 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
108 FULL BLOOD COUNT DECREASED 58 0.0029
109 JOINT ABSCESS 1 0.0029
110 LUNG CONSOLIDATION 8 0.0029
111 RADIATION INJURY 3 0.0028
112 METASTASES TO LIVER 49 0.0028
113 LIVER FUNCTION TEST DECREASED 1 0.0028
114 LOSS OF LIBIDO 25 0.0028
115 BONE LESION 10 0.0028
116 CEREBRAL MASS EFFECT 1 0.0028
117 ABSCESS BACTERIAL 1 0.0028
118 PHIMOSIS 2 0.0027
119 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
120 ENTEROVESICAL FISTULA 2 0.0026
121 MEDIASTINAL MASS 1 0.0026
122 CEREBELLAR STROKE 1 0.0026
123 ARACHNOID CYST 1 0.0025
124 PRODUCT INEFFECTIVE 2 0.0025
125 AORTIC DISORDER 2 0.0025
126 BRAIN COMPRESSION 1 0.0025
127 GLOMERULAR FILTRATION RATE INCREASED 2 0.0024
128 INFUSION 1 0.0024
129 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 3 0.0024
130 BONE FISSURE 1 0.0024
131 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
132 HYPOTONY OF EYE 1 0.0024
133 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
134 APTYALISM 2 0.0023
135 BLADDER NEOPLASM 4 0.0023
136 HEPATIC CANCER METASTATIC 2 0.0023
137 CRANIOFACIAL FRACTURE 2 0.0023
138 BILIARY OBSTRUCTION 3 0.0023
139 SPINAL CORD NEOPLASM 2 0.0023
140 BLOOD TEST ABNORMAL 32 0.0023
141 FACIAL NERVE DISORDER 1 0.0023
142 METASTASES TO PANCREAS 1 0.0023
143 TERMINAL INSOMNIA 4 0.0023
144 CREATININE RENAL CLEARANCE DECREASED 9 0.0022
145 ANION GAP INCREASED 3 0.0022
146 BLOOD CREATININE DECREASED 7 0.0022
147 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
148 ANAEMIA OF CHRONIC DISEASE 2 0.0022
149 MUSCLE MASS 1 0.0022
150 CYTOPENIA 27 0.0022
151 URETERIC OBSTRUCTION 3 0.0022
152 METASTASES TO MENINGES 5 0.0022
153 EATING DISORDER SYMPTOM 1 0.0022
154 BLOOD UREA ABNORMAL 2 0.0021
155 URINARY TRACT OBSTRUCTION 5 0.0021
156 NORMOCYTIC ANAEMIA 3 0.0020
157 METASTASES TO ABDOMINAL CAVITY 1 0.0020
158 ANAEMIA VITAMIN B12 DEFICIENCY 1 0.0020
159 HYPOGONADISM 2 0.0020
160 MEAN CELL VOLUME INCREASED 5 0.0019
161 BLADDER OBSTRUCTION 1 0.0019
162 CORONAVIRUS TEST POSITIVE 2 0.0019
163 FULL BLOOD COUNT ABNORMAL 20 0.0019
164 COATING IN MOUTH 1 0.0019
165 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
166 HYDRONEPHROSIS 14 0.0019
167 GINGIVAL DISCOLOURATION 1 0.0019
168 IRIS DISORDER 1 0.0019
169 BONE NEOPLASM 2 0.0019
170 HYPERAMYLASAEMIA 1 0.0018
171 GASTROENTERITIS ESCHERICHIA COLI 1 0.0018
172 BLOOD CREATINE INCREASED 8 0.0018
173 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
174 DISEASE COMPLICATION 8 0.0017
175 FAILURE TO THRIVE 9 0.0017
176 WRONG PATIENT RECEIVED PRODUCT 5 0.0017
177 IRREGULAR BREATHING 1 0.0017
178 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
179 PARAPARESIS 3 0.0017
180 PROSTATE CANCER 135 0.0017
181 ANAL ABSCESS 9 0.0017
182 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 1 0.0017
183 BONE MARROW DISORDER 5 0.0017
184 MONOCYTE COUNT DECREASED 2 0.0016
185 HAEMATOCRIT ABNORMAL 2 0.0016
186 ILLNESS 165 0.0016
187 GLOMERULOSCLEROSIS 1 0.0016
188 PLATELET COUNT DECREASED 168 0.0016
189 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
190 ENDOCRINE DISORDER 2 0.0016
191 HAEMOGLOBIN ABNORMAL 10 0.0016
192 HAEMOGLOBIN DECREASED 159 0.0015
193 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
194 DEATH 1321 0.0015
195 BICYTOPENIA 3 0.0015
196 ANISOCYTOSIS 1 0.0015
197 PERFORMANCE STATUS DECREASED 7 0.0015
198 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
199 DRY MOUTH 120 0.0015
200 BEHAVIOUR DISORDER 8 0.0015
201 SIALOADENITIS 2 0.0015
202 EXTRAVASATION 6 0.0015
203 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
204 MYELOSUPPRESSION 51 0.0014
205 GLOMERULAR FILTRATION RATE ABNORMAL 2 0.0014
206 MONOCYTE PERCENTAGE INCREASED 1 0.0014
207 METASTASIS 10 0.0014
208 NONINFECTIVE ENCEPHALITIS 1 0.0014
209 PARAPLEGIA 4 0.0014
210 VASCULAR INJURY 2 0.0014
211 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
212 CLONIC CONVULSION 1 0.0014
213 IRON DEFICIENCY 6 0.0013
214 THROMBOCYTOPENIA 147 0.0013
215 PANCYTOPENIA 73 0.0013
216 MALIGNANT ASCITES 1 0.0013
217 CAUDA EQUINA SYNDROME 1 0.0013
218 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
219 INFECTION PARASITIC 1 0.0013
220 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 1 0.0013
221 SUBDURAL HAEMATOMA 18 0.0013
222 HAEMOPERITONEUM 1 0.0012
223 LYMPHANGITIS 1 0.0012
224 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
225 BALANOPOSTHITIS 1 0.0012
226 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
227 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
228 MEAN PLATELET VOLUME DECREASED 1 0.0012
229 FOOD AVERSION 2 0.0012
230 GLIOBLASTOMA 2 0.0012
231 BLOOD CREATININE ABNORMAL 4 0.0012
232 HEPATIC LESION 5 0.0012
233 GENITAL BURNING SENSATION 1 0.0012
234 BONE CANCER 5 0.0011
235 HAEMATURIA 39 0.0011
236 HILAR LYMPHADENOPATHY 1 0.0011
237 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
238 HYPERLEUKOCYTOSIS 1 0.0011
239 METASTASES TO LUNG 13 0.0011
240 CANDIDA SEPSIS 1 0.0011
241 HAEMATOCRIT DECREASED 22 0.0011
242 ANAEMIA 204 0.0011
243 NEPHROPATHY TOXIC 12 0.0011
244 PROTEIN TOTAL DECREASED 4 0.0011
245 BRAIN STEM HAEMORRHAGE 1 0.0011
246 TUMOUR MARKER INCREASED 5 0.0010
247 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
248 HEMIANOPIA 1 0.0010
249 VITAMIN B12 DEFICIENCY 4 0.0010
250 PENILE PAIN 3 0.0010
251 PATHOLOGICAL FRACTURE 5 0.0010
252 EYE COLOUR CHANGE 1 0.0010
253 METASTASES TO PLEURA 1 0.0010
254 RED BLOOD CELL COUNT DECREASED 27 0.0009
255 GALLBLADDER ENLARGEMENT 1 0.0009
256 METASTATIC NEOPLASM 4 0.0009
257 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
258 OCULAR TOXICITY 1 0.0009
259 HAEMOGLOBINURIA 1 0.0009
260 CATHETER SITE DISCHARGE 1 0.0009
261 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
262 BLOOD FIBRINOGEN DECREASED 1 0.0009
263 CARBON DIOXIDE DECREASED 1 0.0009
264 BREAKTHROUGH PAIN 2 0.0009
265 NEUROLOGICAL DECOMPENSATION 2 0.0009
266 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
267 JAUNDICE CHOLESTATIC 3 0.0008
268 FULL BLOOD COUNT INCREASED 1 0.0008
269 URINE FLOW DECREASED 2 0.0008
270 BILE DUCT STENOSIS 1 0.0008
271 COVID-19 146 0.0008
272 FACIAL PARALYSIS 7 0.0008
273 AMYLASE INCREASED 3 0.0008
274 INFUSION SITE EXTRAVASATION 5 0.0008
275 BLOOD CALCIUM DECREASED 9 0.0008
276 PLATELET DISORDER 2 0.0008
277 MALLORY-WEISS SYNDROME 1 0.0008
278 HAEMORRHAGE URINARY TRACT 2 0.0008
279 BLOOD BILIRUBIN ABNORMAL 1 0.0008
280 CACHEXIA 4 0.0008
281 PHYSICAL DECONDITIONING 2 0.0008
282 RHINOVIRUS INFECTION 3 0.0008
283 DRUG CLEARANCE DECREASED 1 0.0008
284 LIP INJURY 1 0.0008
285 INCONTINENCE 8 0.0008
286 APPETITE DISORDER 5 0.0008
287 WHITE BLOOD CELL DISORDER 2 0.0007
288 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
289 LYMPHOCYTE COUNT DECREASED 13 0.0007
290 SUBDURAL HAEMORRHAGE 2 0.0007
291 ABSCESS ORAL 1 0.0007
292 BILIARY TRACT DISORDER 1 0.0007
293 SECOND PRIMARY MALIGNANCY 6 0.0007
294 HYPERTRANSAMINASAEMIA 5 0.0007
295 THERAPY NON-RESPONDER 32 0.0007
296 FANCONI SYNDROME 1 0.0007
297 NEUROENDOCRINE TUMOUR 1 0.0007
298 INTENSIVE CARE 1 0.0007
299 HEPATIC PAIN 3 0.0007
300 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
301 INVESTIGATION ABNORMAL 1 0.0007
302 NOROVIRUS INFECTION 1 0.0007
303 NONINFECTIVE GINGIVITIS 1 0.0007
304 COMA SCALE ABNORMAL 2 0.0007
305 URINARY RETENTION 23 0.0007
306 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
307 HYPOCALCAEMIA 13 0.0007
308 DIVERTICULUM INTESTINAL 3 0.0007
309 ACUTE ABDOMEN 1 0.0007
310 LEUKOPENIA 34 0.0007
311 HYPOPHOSPHATAEMIA 5 0.0007
312 BRAIN HERNIATION 2 0.0007
313 MENTAL FATIGUE 1 0.0007
314 METABOLIC ENCEPHALOPATHY 2 0.0007
315 PLATELET COUNT ABNORMAL 4 0.0007
316 GENITAL HERPES 1 0.0007
317 LOCALISED OEDEMA 3 0.0006
318 RENAL FUNCTION TEST ABNORMAL 3 0.0006
319 BRONCHIAL DISORDER 1 0.0006
320 UMBILICAL HERNIA 3 0.0006
321 TESTICULAR PAIN 2 0.0006
322 BLOOD ALBUMIN DECREASED 5 0.0006
323 BILE DUCT STONE 2 0.0006
324 HYPOVOLAEMIC SHOCK 3 0.0006
325 MALNUTRITION 7 0.0006
326 MYELODYSPLASTIC SYNDROME 9 0.0006
327 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
328 DISINHIBITION 1 0.0006
329 ACUTE LEUKAEMIA 1 0.0006
330 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
331 LIVER FUNCTION TEST INCREASED 13 0.0006
332 SKIN INJURY 2 0.0006
333 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
334 CEREBRAL HAEMATOMA 2 0.0006
335 MALIGNANT PLEURAL EFFUSION 1 0.0006
336 WRONG PRODUCT ADMINISTERED 4 0.0006
337 TASTE DISORDER 12 0.0006
338 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
339 BLOOD TESTOSTERONE DECREASED 4 0.0006
340 BONE PAIN 34 0.0006
341 CERVICAL VERTEBRAL FRACTURE 2 0.0006
342 BLOOD URINE PRESENT 11 0.0006
343 BLOOD CHLORIDE INCREASED 1 0.0006
344 KIDNEY FIBROSIS 1 0.0006
345 KYPHOSIS 1 0.0006
346 PROSTATE CANCER STAGE IV 2 0.0006
347 GLOSSITIS 2 0.0006
348 RENAL IMPAIRMENT 47 0.0006
349 CEREBRAL HAEMORRHAGE 20 0.0006
350 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
351 MONOPARESIS 1 0.0006
352 ESSENTIAL HYPERTENSION 1 0.0005
353 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
354 THROMBOCYTOSIS 2 0.0005
355 UROSEPSIS 5 0.0005
356 HEART RATE ABNORMAL 3 0.0005
357 LYMPH NODE PAIN 1 0.0005
358 ADENOCARCINOMA OF COLON 1 0.0005
359 BLOOD BICARBONATE DECREASED 1 0.0005
360 TROPONIN INCREASED 4 0.0005
361 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
362 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
363 LIPASE INCREASED 4 0.0005
364 HYPOREFLEXIA 1 0.0005
365 ADRENAL DISORDER 1 0.0005
366 ELECTROLYTE IMBALANCE 6 0.0005
367 HYPOALBUMINAEMIA 4 0.0005
368 ATROPHY 1 0.0005
369 FAECES HARD 2 0.0005
370 EARLY SATIETY 1 0.0005
371 THROMBOTIC MICROANGIOPATHY 5 0.0005
372 SPINAL PAIN 6 0.0005
373 HYPOGEUSIA 1 0.0005
374 JOINT NOISE 1 0.0005
375 OCCULT BLOOD POSITIVE 1 0.0005
376 NAIL DISCOLOURATION 2 0.0005
377 DIPLEGIA 1 0.0005
378 GENE MUTATION 1 0.0005
379 ANORECTAL DISORDER 1 0.0005
380 ABSCESS 8 0.0005
381 OBSTRUCTION 2 0.0005
382 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
383 CARDIAC DISCOMFORT 1 0.0005
384 LYMPHOPENIA 7 0.0005
385 BONE MARROW FAILURE 10 0.0005
386 NEUTROPHIL COUNT INCREASED 5 0.0005
387 OSTEONECROSIS OF JAW 12 0.0005
388 SPINAL STENOSIS 2 0.0005
389 CHOLANGITIS 3 0.0005
390 CHEST INJURY 1 0.0005
391 HYPERBILIRUBINAEMIA 5 0.0005
392 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
393 MUSCLE FATIGUE 2 0.0005
394 HIP FRACTURE 15 0.0005
395 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
396 EXOPHTHALMOS 1 0.0005
397 JAW FRACTURE 1 0.0005
398 EXPOSED BONE IN JAW 1 0.0005
399 PLEURAL EFFUSION 28 0.0005
400 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
401 NOSOCOMIAL INFECTION 1 0.0005
402 MIDDLE EAR EFFUSION 1 0.0005
403 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
404 MUSCULOSKELETAL CHEST PAIN 7 0.0005
405 FAECES PALE 1 0.0004
406 CHOLESTATIC LIVER INJURY 1 0.0004
407 ADENOCARCINOMA 1 0.0004
408 FEAR OF DEATH 1 0.0004
409 URINARY TRACT DISORDER 2 0.0004
410 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
411 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
412 BLOOD LOSS ANAEMIA 1 0.0004
413 AGEUSIA 11 0.0004
414 NEOPLASM 5 0.0004
415 DRUG INTOLERANCE 42 0.0004
416 YELLOW SKIN 2 0.0004
417 ARTERIOSCLEROSIS 4 0.0004
418 EATING DISORDER 9 0.0004
419 BACTERAEMIA 5 0.0004
420 PRODUCT SUPPLY ISSUE 3 0.0004
421 EOSINOPHIL COUNT DECREASED 1 0.0004
422 BLOOD UREA INCREASED 7 0.0004
423 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
424 WHITE BLOOD CELL COUNT DECREASED 45 0.0004
425 HUMERUS FRACTURE 2 0.0004
426 BLOOD CREATININE INCREASED 27 0.0004
427 GLOMERULONEPHRITIS 1 0.0004
428 EYE OEDEMA 1 0.0004
429 DERMAL CYST 1 0.0004
430 HYPERCALCAEMIA 5 0.0004
431 ACUTE PSYCHOSIS 1 0.0004
432 INFLAMMATORY MARKER INCREASED 2 0.0004
433 NEOPLASM PROGRESSION 14 0.0004
434 HEPATIC ENZYME ABNORMAL 2 0.0004
435 METASTASES TO PERITONEUM 1 0.0004
436 APPENDICITIS PERFORATED 1 0.0004
437 SUBARACHNOID HAEMORRHAGE 4 0.0004
438 NEUTROPHIL COUNT DECREASED 16 0.0004
439 MOTOR DYSFUNCTION 4 0.0004
440 HEPATIC CYTOLYSIS 5 0.0004
441 BOWEL MOVEMENT IRREGULARITY 3 0.0004
442 FEMORAL NECK FRACTURE 2 0.0004
443 BLOOD CHLORIDE DECREASED 1 0.0004
444 TEMPERATURE INTOLERANCE 4 0.0004
445 FEMUR FRACTURE 12 0.0004
446 PETECHIAE 4 0.0004
447 SERUM FERRITIN INCREASED 2 0.0004
448 RENAL CYST 3 0.0004
449 GINGIVAL PAIN 3 0.0004
450 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
451 QUALITY OF LIFE DECREASED 5 0.0004
452 GINGIVAL BLEEDING 5 0.0004
453 JAW DISORDER 2 0.0004
454 CHOLESTASIS 7 0.0004
455 HYPERKERATOSIS 2 0.0004
456 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
457 NECROSIS 2 0.0004
458 NEUROPATHY PERIPHERAL 34 0.0004
459 DECREASED APPETITE 83 0.0004
460 ANAL HAEMORRHAGE 1 0.0004
461 ACUTE PULMONARY OEDEMA 2 0.0004
462 DRUG TOLERANCE DECREASED 1 0.0004
463 ATYPICAL FEMUR FRACTURE 1 0.0004
464 NEUTROPHIL COUNT ABNORMAL 1 0.0004
465 OESOPHAGEAL STENOSIS 1 0.0004
466 CARDIAC VALVE DISEASE 2 0.0003
467 BLOOD URIC ACID INCREASED 2 0.0003
468 ESCHERICHIA SEPSIS 1 0.0003
469 URINE OUTPUT DECREASED 3 0.0003
470 GASTROENTERITIS 5 0.0003
471 BLOOD CALCIUM INCREASED 3 0.0003
472 SPINAL OSTEOARTHRITIS 3 0.0003
473 TUMOUR LYSIS SYNDROME 3 0.0003
474 CHOLECYSTITIS 4 0.0003
475 HAEMORRHAGE INTRACRANIAL 5 0.0003
476 SYMPTOM RECURRENCE 2 0.0003
477 CRANIOCEREBRAL INJURY 1 0.0003
478 NEOPLASM MALIGNANT 22 0.0003
479 DYSCHEZIA 1 0.0003
480 ASTHENIA 123 0.0003
481 FIBROSIS 1 0.0003
482 PIGMENTATION DISORDER 2 0.0003
483 THERAPY PARTIAL RESPONDER 5 0.0003
484 MALAISE 140 0.0003
485 BLOOD SODIUM DECREASED 6 0.0003
486 FRACTURE 6 0.0003
487 RENAL FAILURE 42 0.0003
488 HEAD INJURY 10 0.0003
489 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
490 EXPOSURE TO TOXIC AGENT 1 0.0003
491 ACUTE RESPIRATORY FAILURE 6 0.0003
492 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
493 CUSHINGOID 1 0.0003
494 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
495 PROCTALGIA 2 0.0003
496 ATELECTASIS 3 0.0003
497 CHROMATURIA 7 0.0003
498 UNRESPONSIVE TO STIMULI 8 0.0003
499 FACET JOINT SYNDROME 1 0.0003
500 FATIGUE 238 0.0003
501 SPINAL FRACTURE 6 0.0003
502 HEPATIC FAILURE 9 0.0003
503 PRODUCT ADMINISTRATION ERROR 6 0.0003
504 BLOOD BILIRUBIN INCREASED 8 0.0003
505 CLOSTRIDIAL INFECTION 1 0.0003
506 NEOPLASM RECURRENCE 1 0.0003
507 TOOTH ABSCESS 3 0.0003
508 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
509 NEPHROTIC SYNDROME 2 0.0003
510 LYMPHOEDEMA 2 0.0003
511 BACK PAIN 67 0.0003
512 ACUTE KIDNEY INJURY 44 0.0003
513 HYPOMAGNESAEMIA 4 0.0003
514 EMBOLIC STROKE 1 0.0003
515 LYMPHADENOPATHY 10 0.0003
516 NEUTROPENIC SEPSIS 2 0.0003
517 HOT FLUSH 21 0.0003
518 DECREASED ACTIVITY 3 0.0003
519 C-REACTIVE PROTEIN INCREASED 10 0.0003
520 ASPIRATION 3 0.0003
521 HYPOPHAGIA 7 0.0003
522 FOOD INTOLERANCE 1 0.0003
523 CEREBRAL DISORDER 2 0.0003
524 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
525 SEPSIS 30 0.0003
526 RESPIRATORY TRACT INFECTION 7 0.0003
527 SKIN INFECTION 3 0.0003
528 CATHETER SITE INFECTION 1 0.0003
529 FACE INJURY 1 0.0003
530 MICTURITION URGENCY 3 0.0003
531 JAUNDICE 7 0.0003
532 WEIGHT DECREASED 72 0.0003
533 BRAIN FOG 4 0.0003
534 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
535 DEHYDRATION 34 0.0003
536 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
537 BLOOD IRON DECREASED 3 0.0003
538 SEPTIC SHOCK 11 0.0003
539 PNEUMOTHORAX 4 0.0003
540 MENTAL STATUS CHANGES 7 0.0003
541 HYPERLIPIDAEMIA 3 0.0003
542 SCIATICA 4 0.0003
543 BLOOD DISORDER 2 0.0002
544 INFECTION 36 0.0002
545 SENSORY LOSS 2 0.0002
546 ENURESIS 1 0.0002
547 BLOOD POTASSIUM INCREASED 4 0.0002
548 DECUBITUS ULCER 2 0.0002
549 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
550 ARTHRITIS BACTERIAL 1 0.0002
551 HYPERURICAEMIA 1 0.0002
552 CARDIAC FAILURE 19 0.0002
553 URINARY INCONTINENCE 7 0.0002
554 BUNDLE BRANCH BLOCK LEFT 1 0.0002
555 ABSCESS LIMB 1 0.0002
556 CARDIAC FAILURE CHRONIC 1 0.0002
557 MYDRIASIS 3 0.0002
558 APHASIA 7 0.0002
559 FAECES DISCOLOURED 5 0.0002
560 MONOPLEGIA 1 0.0002
561 PLATELET COUNT INCREASED 3 0.0002
562 ORTHOSTATIC HYPOTENSION 4 0.0002
563 DEAFNESS 6 0.0002
564 URINARY TRACT INFECTION 39 0.0002
565 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
566 HYPOXIA 8 0.0002
567 ADVERSE REACTION 3 0.0002
568 ISCHAEMIC STROKE 4 0.0002
569 GASTROINTESTINAL INFECTION 2 0.0002
570 ANAL INCONTINENCE 2 0.0002
571 TOOTHACHE 4 0.0002
572 PALLOR 6 0.0002
573 PELVIC PAIN 4 0.0002
574 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
575 BONE DISORDER 4 0.0002
576 HAEMOGLOBIN INCREASED 1 0.0002
577 ABDOMINAL HERNIA 1 0.0002
578 SKIN LESION 6 0.0002
579 LUMBAR VERTEBRAL FRACTURE 1 0.0002
580 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
581 DIVERTICULITIS 6 0.0002
582 CONSTIPATION 47 0.0002
583 DEMENTIA 6 0.0002
584 APPENDICITIS 2 0.0002
585 FLANK PAIN 2 0.0002
586 LEUKAEMIA 2 0.0002
587 SPINAL DISORDER 2 0.0002
588 HAEMORRHAGE 22 0.0002
589 PARALYSIS 3 0.0002
590 GAIT INABILITY 7 0.0002
591 GASTROINTESTINAL TOXICITY 1 0.0002
592 ENTEROCOCCAL INFECTION 1 0.0002
593 HEPATOMEGALY 2 0.0002
594 BLADDER DISORDER 2 0.0002
595 FALL 67 0.0002
596 BRAIN INJURY 2 0.0002
597 DYSLIPIDAEMIA 1 0.0002
598 NEPHROLITHIASIS 9 0.0002
599 HEPATITIS 5 0.0002
600 HYPONATRAEMIA 11 0.0002
601 ATRIAL FIBRILLATION 19 0.0002
602 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
603 EJECTION FRACTION DECREASED 3 0.0002
604 DYSURIA 7 0.0002
605 ANORECTAL DISCOMFORT 1 0.0002
606 RETCHING 4 0.0002
607 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
608 COMPRESSION FRACTURE 1 0.0002
609 NIGHT SWEATS 6 0.0002
610 INTESTINAL OBSTRUCTION 7 0.0002
611 PNEUMONIA 60 0.0002
612 NAUSEA 146 0.0002
613 NEUTROPENIA 25 0.0002
614 DRY EYE 9 0.0002
615 HEPATOTOXICITY 4 0.0002
616 INFLUENZA 20 0.0002
617 PULMONARY EMBOLISM 17 0.0002
618 MACULAR OEDEMA 1 0.0002
619 INTESTINAL PERFORATION 2 0.0002
620 NEUTROPHILIA 1 0.0002
621 NEUROLOGICAL SYMPTOM 1 0.0002
622 EXERCISE TOLERANCE DECREASED 1 0.0002
623 HYPOKALAEMIA 8 0.0002
624 DYSSTASIA 5 0.0002
625 HYPERKALAEMIA 6 0.0002
626 ASCITES 5 0.0002
627 PAIN 104 0.0002
628 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
629 TREATMENT FAILURE 14 0.0002
630 ACCIDENT 2 0.0002
631 POLYNEUROPATHY 2 0.0002
632 VOMITING 78 0.0002
633 BURSITIS 2 0.0002
634 SMALL INTESTINAL OBSTRUCTION 2 0.0002
635 GENERALISED OEDEMA 2 0.0002
636 OLIGURIA 1 0.0002
637 BACTERIAL INFECTION 3 0.0002
638 TOXICITY TO VARIOUS AGENTS 27 0.0002
639 PNEUMONIA ASPIRATION 4 0.0002
640 SYNCOPE 16 0.0002
641 DYSPNOEA EXERTIONAL 6 0.0002
642 MUSCULAR WEAKNESS 18 0.0002
643 TACHYCARDIA 14 0.0002
644 HYPOTHYROIDISM 5 0.0002
645 INFLAMMATION 8 0.0002
646 HIATUS HERNIA 2 0.0002
647 HAEMATOMA 4 0.0002
648 MOBILITY DECREASED 11 0.0002
649 UNDERDOSE 11 0.0002
650 MENINGITIS 1 0.0001
651 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
652 STOMATITIS 9 0.0001
653 FEEDING DISORDER 3 0.0001
654 RASH PRURITIC 8 0.0001
655 DYSPHAGIA 14 0.0001
656 UVEITIS 2 0.0001
657 HEPATIC ENZYME INCREASED 10 0.0001
658 INFARCTION 1 0.0001
659 EYE MOVEMENT DISORDER 1 0.0001
660 PERIPHERAL COLDNESS 2 0.0001
661 PULMONARY HYPERTENSION 3 0.0001
662 HAEMOPTYSIS 4 0.0001
663 CARPAL TUNNEL SYNDROME 2 0.0001
664 DEFAECATION URGENCY 1 0.0001
665 DEVICE OCCLUSION 2 0.0001
666 DUODENAL ULCER 1 0.0001
667 CEREBROVASCULAR ACCIDENT 24 0.0001
668 SEASONAL ALLERGY 2 0.0001
669 CARDIAC DISORDER 13 0.0001
670 HYPOKINESIA 2 0.0001
671 LIVER FUNCTION TEST ABNORMAL 4 0.0001
672 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
673 LIVER DISORDER 6 0.0001
674 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
675 TRANSAMINASES INCREASED 3 0.0001
676 TOOTH DISORDER 3 0.0001
677 DYSGEUSIA 10 0.0001
678 PULMONARY MASS 2 0.0001
679 HEPATIC FUNCTION ABNORMAL 5 0.0001
680 GASTROINTESTINAL DISORDER 12 0.0001
681 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
682 PYREXIA 46 0.0001
683 HEPATOCELLULAR CARCINOMA 1 0.0001
684 HYPERTHERMIA 1 0.0001
685 ACIDOSIS 1 0.0001
686 SKIN DISCOLOURATION 6 0.0001
687 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
688 DEVICE RELATED INFECTION 2 0.0001
689 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
690 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
691 APHTHOUS ULCER 1 0.0001
692 APNOEA 1 0.0001
693 ACUTE MYELOID LEUKAEMIA 2 0.0001
694 NERVOUS SYSTEM DISORDER 4 0.0001
695 MENINGIOMA 2 0.0001
696 HAEMORRHAGIC STROKE 1 0.0001
697 HAEMATOCHEZIA 7 0.0001
698 PRODUCTIVE COUGH 6 0.0001
699 CYSTITIS 4 0.0001
700 RASH ERYTHEMATOUS 6 0.0001
701 FRUSTRATION TOLERANCE DECREASED 1 0.0001
702 PERIPHERAL SWELLING 19 0.0001
703 PAIN IN EXTREMITY 36 0.0001
704 ABNORMAL FAECES 1 0.0001
705 HICCUPS 1 0.0001
706 HERPES ZOSTER 7 0.0001
707 HYPERAESTHESIA 1 0.0001
708 LETHARGY 7 0.0001
709 VIRAL INFECTION 4 0.0001
710 COAGULOPATHY 2 0.0001
711 POLLAKIURIA 5 0.0001
712 CELLULITIS 6 0.0001
713 ABDOMINAL PAIN LOWER 3 0.0001
714 HAEMATEMESIS 3 0.0001
715 ERECTILE DYSFUNCTION 3 0.0001
716 RECTAL HAEMORRHAGE 5 0.0001
717 MUSCULOSKELETAL DISCOMFORT 2 0.0001
718 ABDOMINAL PAIN 27 0.0001
719 BLOOD MAGNESIUM DECREASED 1 0.0001
720 DELIRIUM 4 0.0001
721 HYPOTENSION 23 0.0001
722 MYOCARDIAL INFARCTION 20 0.0001
723 CONTUSION 11 0.0001
724 GASTRITIS 3 0.0001
725 GROIN PAIN 1 0.0001
726 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
727 CARDIOTOXICITY 1 0.0001
728 FACIAL PAIN 1 0.0001
729 GOUT 2 0.0001
730 LEUKOCYTOSIS 2 0.0001
731 GAIT DISTURBANCE 21 0.0001
732 RESPIRATORY FAILURE 8 0.0001
733 BRAIN NEOPLASM 1 0.0001
734 CONDITION AGGRAVATED 33 0.0001
735 NERVE COMPRESSION 1 0.0001
736 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
737 DEEP VEIN THROMBOSIS 7 0.0001
738 RENAL DISORDER 5 0.0001
739 HEPATIC ENCEPHALOPATHY 1 0.0001
740 OEDEMA PERIPHERAL 13 0.0001
741 DYSARTHRIA 4 0.0001
742 PAIN IN JAW 3 0.0001
743 COLITIS 4 0.0001
744 CHRONIC KIDNEY DISEASE 8 0.0001
745 HYPERSOMNIA 3 0.0001
746 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
747 LOWER LIMB FRACTURE 2 0.0001
748 GLAUCOMA 2 0.0001
749 HYPERCHOLESTEROLAEMIA 1 0.0001
750 ERUCTATION 2 0.0001
751 LUNG DISORDER 5 0.0001
752 ACUTE MYOCARDIAL INFARCTION 3 0.0001
753 LIGAMENT SPRAIN 1 0.0001
754 DIARRHOEA 65 0.0001
755 RESPIRATORY DISORDER 3 0.0001
756 THROMBOSIS 8 0.0001
757 LACRIMATION INCREASED 3 0.0001
758 CORONARY ARTERY DISEASE 3 0.0001
759 CONFUSIONAL STATE 16 0.0001
760 EYELID PTOSIS 1 0.0001
761 DRY THROAT 1 0.0001
762 FLUID RETENTION 5 0.0001
763 INFLUENZA LIKE ILLNESS 8 0.0001
764 CHEST PAIN 18 0.0001
765 DYSPNOEA 55 0.0001
766 PERITONITIS 2 0.0001
767 DRUG INEFFECTIVE 127 0.0001
768 EYE DISCHARGE 1 0.0001
769 ARTHRALGIA 40 0.0001
770 SWOLLEN TONGUE 3 0.0001
771 RHABDOMYOLYSIS 4 0.0001
772 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
773 ROAD TRAFFIC ACCIDENT 4 0.0001
774 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
775 METABOLIC ACIDOSIS 3 0.0001
776 POOR QUALITY SLEEP 2 0.0001
777 LACTIC ACIDOSIS 3 0.0001
778 BALANCE DISORDER 8 0.0001
779 BACK INJURY 1 0.0001
780 PRODUCT DISPENSING ERROR 2 0.0001
781 OESOPHAGITIS 1 0.0001
782 MELAENA 2 0.0001
783 FEBRILE NEUTROPENIA 6 0.0001
784 VISUAL ACUITY REDUCED 3 0.0001
785 EXPIRED PRODUCT ADMINISTERED 3 0.0001
786 ORAL PAIN 2 0.0001
787 OCULAR DISCOMFORT 1 0.0001
788 PANCREATITIS ACUTE 2 0.0001
789 FISTULA 1 0.0001
790 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
791 EYE INFECTION 1 0.0001
792 MITRAL VALVE INCOMPETENCE 1 0.0001
793 PRODUCT AVAILABILITY ISSUE 2 0.0001
794 CARDIAC FAILURE CONGESTIVE 7 0.0001
795 PERICARDIAL EFFUSION 2 0.0001
796 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
797 ATAXIA 1 0.0001
798 ADRENAL INSUFFICIENCY 1 0.0001
799 NOCTURIA 1 0.0001
800 HYPERGLYCAEMIA 3 0.0001
801 LIVER INJURY 2 0.0001
802 VISUAL IMPAIRMENT 10 0.0001
803 EYE SWELLING 3 0.0001
804 BLOOD GLUCOSE INCREASED 15 0.0001
805 BRAIN OEDEMA 1 0.0001
806 INTRAOCULAR PRESSURE INCREASED 1 0.0001
807 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
808 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
809 MUCOSAL INFLAMMATION 2 0.0001
810 SEDATION 2 0.0001
811 ADVERSE EVENT 7 0.0001
812 IMMUNE SYSTEM DISORDER 1 0.0001
813 PANCREATITIS 4 0.0001
814 EYE HAEMORRHAGE 1 0.0001
815 LIMB INJURY 2 0.0001
816 BLINDNESS 3 0.0001
817 PNEUMONITIS 2 0.0001
818 OSTEOPOROSIS 3 0.0001
819 RESPIRATORY DISTRESS 2 0.0001
820 CARDIO-RESPIRATORY ARREST 3 0.0001
821 APHONIA 1 0.0001
822 MASS 1 0.0001
823 BURNING SENSATION 5 0.0001
824 OXYGEN SATURATION DECREASED 4 0.0001
825 BLINDNESS UNILATERAL 1 0.0001
826 PARAESTHESIA 11 0.0001
827 CARDIOGENIC SHOCK 1 0.0001
828 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
829 INSOMNIA 18 0.0001
830 WHEEZING 4 0.0001
831 CATARACT 4 0.0001
832 COLON CANCER 1 0.0001
833 IMMUNODEFICIENCY 1 0.0001
834 PULMONARY OEDEMA 3 0.0001
835 FEELING ABNORMAL 16 0.0001
836 HYPOAESTHESIA ORAL 1 0.0001
837 DISCOMFORT 4 0.0001
838 LYMPHOMA 1 0.0001
839 DIZZINESS 32 0.0001
840 OFF LABEL USE 56 0.0001
841 OCULAR HYPERAEMIA 3 0.0001
842 COMA 3 0.0001
843 LOSS OF CONSCIOUSNESS 8 0.0001
844 MOVEMENT DISORDER 2 0.0001
845 AMNESIA 4 0.0001
846 OSTEONECROSIS 2 0.0001
847 STAPHYLOCOCCAL INFECTION 2 0.0001
848 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
849 HYPOAESTHESIA 9 0.0001
850 TYPE 2 DIABETES MELLITUS 2 0.0001
851 FACE OEDEMA 1 0.0001
852 CANDIDA INFECTION 1 0.0001
853 HEMIPARESIS 1 0.0001
854 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
855 EOSINOPHILIA 1 0.0001
856 HYPERTENSION 12 0.0001
857 GALLBLADDER DISORDER 1 0.0001
858 GASTROENTERITIS VIRAL 1 0.0001
859 OEDEMA 3 0.0001
860 END STAGE RENAL DISEASE 1 0.0001
861 BLOOD GLUCOSE ABNORMAL 1 0.0001
862 BRONCHITIS 4 0.0001
863 MEDICATION ERROR 3 0.0001
864 CONJUNCTIVITIS 1 0.0001
865 AGRANULOCYTOSIS 1 0.0001
866 HEPATIC STEATOSIS 1 0.0001
867 NECK PAIN 3 0.0001
868 ABDOMINAL DISCOMFORT 9 0.0001
869 EPISTAXIS 4 0.0001
870 SWELLING 5 0.0001
871 EYE PAIN 3 0.0001
872 MYALGIA 9 0.0001
873 UNEVALUABLE EVENT 4 0.0001
874 FOOT FRACTURE 1 0.0001
875 GASTRIC ULCER 1 0.0001
876 MUSCULOSKELETAL DISORDER 1 0.0001
877 SEIZURE 6 0.0001
878 HAEMORRHOIDS 1 0.0001
879 CHILLS 6 0.0001
880 KIDNEY INFECTION 1 0.0001
881 DISORIENTATION 2 0.0001
882 JOINT SWELLING 6 0.0000
883 INTENTIONAL SELF-INJURY 1 0.0000
884 VERTIGO 3 0.0000
885 BODY TEMPERATURE INCREASED 1 0.0000
886 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
887 RASH 21 0.0000
888 PRODUCT DOSE OMISSION ISSUE 14 0.0000
889 MOUTH ULCERATION 1 0.0000
890 JOINT INJURY 1 0.0000
891 HYPERHIDROSIS 6 0.0000
892 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
893 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
894 MENTAL DISORDER 2 0.0000
895 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
896 INTENTIONAL PRODUCT MISUSE 4 0.0000
897 MUSCULOSKELETAL STIFFNESS 4 0.0000
898 BLOOD PRESSURE DECREASED 3 0.0000
899 COLITIS ULCERATIVE 2 0.0000
900 GLOSSODYNIA 1 0.0000
901 HEART RATE IRREGULAR 1 0.0000
902 DEPRESSION 10 0.0000
903 MUSCLE SPASMS 8 0.0000
904 HEADACHE 27 0.0000
905 COGNITIVE DISORDER 2 0.0000
906 COUGH 12 0.0000
907 INJURY 3 0.0000
908 DISEASE RECURRENCE 2 0.0000
909 BLOOD PRESSURE FLUCTUATION 1 0.0000
910 LOCALISED INFECTION 1 0.0000
911 MENTAL IMPAIRMENT 1 0.0000
912 NEURALGIA 1 0.0000
913 CEREBRAL INFARCTION 1 0.0000
914 AGITATION 3 0.0000
915 AGGRESSION 2 0.0000
916 CARDIOVASCULAR DISORDER 1 0.0000
917 FLUSHING 4 0.0000
918 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
919 ANXIETY 11 0.0000
920 DIPLOPIA 1 0.0000
921 NERVOUSNESS 2 0.0000
922 MUSCULOSKELETAL PAIN 2 0.0000
923 SPEECH DISORDER 2 0.0000
924 ARTHRITIS 3 0.0000
925 HYPERSENSITIVITY 7 0.0000
926 BRADYCARDIA 2 0.0000
927 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
928 MOOD ALTERED 1 0.0000
929 FLATULENCE 2 0.0000
930 INTENTIONAL DOSE OMISSION 1 0.0000
931 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
932 INCORRECT DOSE ADMINISTERED 8 0.0000
933 PRODUCT STORAGE ERROR 3 0.0000
934 NASAL CONGESTION 2 0.0000
935 ABDOMINAL PAIN UPPER 7 0.0000
936 BLADDER CANCER 2 0.0000
937 DEVICE ISSUE 3 0.0000
938 BLOOD POTASSIUM DECREASED 1 0.0000
939 THERAPEUTIC RESPONSE DECREASED 2 0.0000
940 EPILEPSY 1 0.0000
941 NASOPHARYNGITIS 6 0.0000
942 LIMB DISCOMFORT 1 0.0000
943 EXPOSURE DURING PREGNANCY 2 0.0000
944 BONE DENSITY DECREASED 1 0.0000
945 CHOLELITHIASIS 1 0.0000
946 SOMNOLENCE 6 0.0000
947 PRODUCT QUALITY ISSUE 4 0.0000
948 SINUSITIS 3 0.0000
949 ERYTHEMA 6 0.0000
950 ABDOMINAL DISTENSION 3 0.0000
951 PRURITUS 11 0.0000
952 SLEEP DISORDER 2 0.0000
953 THERAPY INTERRUPTED 2 0.0000
954 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
955 WEIGHT INCREASED 6 0.0000
956 PALPITATIONS 3 0.0000
957 ALOPECIA 5 0.0000
958 EXTRA DOSE ADMINISTERED 1 0.0000
959 LUNG NEOPLASM MALIGNANT 1 0.0000
960 CARDIAC ARREST 2 0.0000
961 COMPLETED SUICIDE 2 0.0000
962 SKIN EXFOLIATION 2 0.0000
963 HYPOACUSIS 1 0.0000
964 DEVICE LEAKAGE 1 0.0000
965 DEVICE DISLOCATION 1 0.0000
966 DRY SKIN 3 0.0000
967 ADVERSE DRUG REACTION 2 0.0000
968 VISION BLURRED 3 0.0000
969 BLOOD CHOLESTEROL INCREASED 1 0.0000
970 ARRHYTHMIA 1 0.0000
971 COLORECTAL CANCER 1 0.0000
972 INTERSTITIAL LUNG DISEASE 1 0.0000
973 HYPOGLYCAEMIA 1 0.0000
974 DYSPEPSIA 2 0.0000
975 HEART RATE INCREASED 2 0.0000
976 BLOOD PRESSURE INCREASED 3 0.0000
977 CHEST DISCOMFORT 2 0.0000
978 DYSPHONIA 1 0.0000
979 FEELING HOT 1 0.0000
980 PRODUCT USE ISSUE 3 0.0000
981 INFUSION RELATED REACTION 1 0.0000
982 MEMORY IMPAIRMENT 2 0.0000
983 DEVICE MALFUNCTION 1 0.0000
984 HALLUCINATION 1 0.0000
985 ACNE 1 0.0000
986 DIABETES MELLITUS 1 0.0000
987 INJECTION SITE PAIN 4 0.0000
988 URTICARIA 2 0.0000
989 NO ADVERSE EVENT 2 0.0000
990 MIGRAINE 1 0.0000
991 OVERDOSE 2 0.0000
992 DRUG INTERACTION 1 0.0000